Cargando…

A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus

Vaccination remains the most effective approach for preventing and controlling equine influenza virus (EIV) in horses. However, the ongoing evolution of EIV has increased the genetic and antigenic differences between currently available vaccines and circulating strains, resulting in suboptimal vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-Lobo, Pilar, Rodriguez, Laura, Reedy, Stephanie, Oladunni, Fatai S., Nogales, Aitor, Murcia, Pablo R., Chambers, Thomas M., Martinez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832603/ https://www.ncbi.nlm.nih.gov/pubmed/31614538 http://dx.doi.org/10.3390/v11100933

Ejemplares similares

Development of a novel equine influenza virus live-attenuated vaccine
por: Rodriguez, Laura, et al.
Publicado: (2018)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Equine Influenza Virus and Vaccines
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018)

Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines
por: Rodriguez, Laura, et al.
Publicado: (2019)

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
por: Nogales, Aitor, et al.
Publicado: (2022)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
por: Hilimire, Thomas A., et al.
Publicado: (2020)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
por: White, Chantelle L., et al.
Publicado: (2021)

Reverse Genetics Approaches for the Development of Influenza Vaccines
por: Nogales, Aitor, et al.
Publicado: (2016)

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
por: Piepenbrink, Michael, et al.
Publicado: (2023)

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
por: Nogales, Aitor, et al.
Publicado: (2022)

A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus
por: Smith, Andrew, et al.
Publicado: (2020)

Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture
por: Jiang, Tian, et al.
Publicado: (2016)

Replication-Competent Influenza A Viruses Expressing Reporter Genes
por: Breen, Michael, et al.
Publicado: (2016)

Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30
por: Rodriguez, Laura, et al.
Publicado: (2018)

A Review on Equine Influenza from a Human Influenza Perspective
por: Whitlock, Fleur, et al.
Publicado: (2022)

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
por: Lorenzo, María M., et al.
Publicado: (2022)

Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins
por: Nogales, Aitor, et al.
Publicado: (2018)

Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X
por: Chiem, Kevin, et al.
Publicado: (2021)

993. Combining Key Residues of the Russian and US Live-Attenuated Influenza Viruses for a More Attenuated Virus
por: Smith, Andrew, et al.
Publicado: (2018)

Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies
por: Breen, Michael, et al.
Publicado: (2016)

Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication
por: Lenartowicz, Elzbieta, et al.
Publicado: (2016)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
por: Nogales, Aitor, et al.
Publicado: (2021)

NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses
por: DeDiego, Marta L., et al.
Publicado: (2016)

An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo
por: Márquez-Jurado, Silvia, et al.
Publicado: (2018)

Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity
por: Nogales, Aitor, et al.
Publicado: (2021)

EHV-1: A Constant Threat to the Horse Industry
por: Oladunni, Fatai S., et al.
Publicado: (2019)

A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1
por: Zarski, Lila M., et al.
Publicado: (2021)

Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo
por: DiPiazza, Anthony, et al.
Publicado: (2017)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Phylogenetically distinct equine influenza viruses show different tropism for the swine respiratory tract
por: Patrono, Livia V., et al.
Publicado: (2015)

Bivalent single domain antibody constructs for effective neutralization of Venezuelan equine encephalitis
por: Liu, Jinny L., et al.
Publicado: (2022)

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Could Interleukin-33 (IL-33) Govern the Outcome of an Equine Influenza Virus Infection? Learning from Other Species
por: Rozario, Christoforos, et al.
Publicado: (2021)

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Influenza Virus and Vaccination
por: Nogales, Aitor, et al.
Publicado: (2020)

Reverse Genetic Approaches for the Generation of Recombinant Zika Virus
por: Ávila-Pérez, Ginés, et al.
Publicado: (2018)

Interferon-Induced Protein 44 Interacts with Cellular FK506-Binding Protein 5, Negatively Regulates Host Antiviral Responses, and Supports Virus Replication
por: DeDiego, Marta L., et al.
Publicado: (2019)

CoDe: a web-based tool for codon deoptimization
por: Sharma, Divya, et al.
Publicado: (2023)

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
por: Cai, Yingyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ak54pm4hgmphub6vjd8b1v48di